Cargando…

U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study

BACKGROUND: Of the over 20 million Americans reporting an opioid use disorder, only around 3 million report receiving treatment of any kind. The gold standard for opioid use disorder treatment is medication in combination with psychosocial support, but despite robust evidence supporting treatment, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohmeier, Kenneth C, Cernasev, Alina, Sensmeier, Megan, Hall, Elizabeth, Webb, Katie, Barenie, Rachel, Cochran, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182209/
https://www.ncbi.nlm.nih.gov/pubmed/34158941
http://dx.doi.org/10.1177/20503121211022994
_version_ 1783704159997919232
author Hohmeier, Kenneth C
Cernasev, Alina
Sensmeier, Megan
Hall, Elizabeth
Webb, Katie
Barenie, Rachel
Cochran, Gerald
author_facet Hohmeier, Kenneth C
Cernasev, Alina
Sensmeier, Megan
Hall, Elizabeth
Webb, Katie
Barenie, Rachel
Cochran, Gerald
author_sort Hohmeier, Kenneth C
collection PubMed
description BACKGROUND: Of the over 20 million Americans reporting an opioid use disorder, only around 3 million report receiving treatment of any kind. The gold standard for opioid use disorder treatment is medication in combination with psychosocial support, but despite robust evidence supporting treatment, barriers are substantial and include limited insurance coverage, patient beliefs, ease of access, regulatory hurdles, and stigma. Although trained as medication experts, U.S. pharmacists are not routinely involved in opioid use disorder treatment and may represent an underutilized care team member. OBJECTIVE: To explore U.S. pharmacy students’ perspectives on pharmacists as providers of methadone-based medications for opioid use disorder treatment. METHODS: A qualitative design with focus groups of student pharmacists in a U.S. college of pharmacy in the Southeastern United States. RESULTS: Over 2 months in 2020, three focus groups were conducted with 15 students in each group participating, and including second-, third-, and fourth-year student pharmacists. Three overarching themes emerged from the data: (1) student pharmacists desire exposure to therapeutic knowledge and lived experiences related to opioid use disorder and methadone treatment, (2) students perceive stigmatizing views held by practicing pharmacists toward opioid use disorder and methadone treatment, (3) pharmacists should play a role in methadone treatment. CONCLUSION: Student pharmacists desire an active and larger role in the care of patients managing opioid use disorder. Findings indicate these students perceive less stigma toward opioid use disorder than currently practicing pharmacists. Pharmacy curricula should emphasize stories of lived experiences of patients with opioid use disorder, therapeutic knowledge and guidelines related to medications for opioid use disorder, and the regulatory environment surrounding opioid use disorder treatment.
format Online
Article
Text
id pubmed-8182209
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81822092021-06-21 U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study Hohmeier, Kenneth C Cernasev, Alina Sensmeier, Megan Hall, Elizabeth Webb, Katie Barenie, Rachel Cochran, Gerald SAGE Open Med Original Research Article BACKGROUND: Of the over 20 million Americans reporting an opioid use disorder, only around 3 million report receiving treatment of any kind. The gold standard for opioid use disorder treatment is medication in combination with psychosocial support, but despite robust evidence supporting treatment, barriers are substantial and include limited insurance coverage, patient beliefs, ease of access, regulatory hurdles, and stigma. Although trained as medication experts, U.S. pharmacists are not routinely involved in opioid use disorder treatment and may represent an underutilized care team member. OBJECTIVE: To explore U.S. pharmacy students’ perspectives on pharmacists as providers of methadone-based medications for opioid use disorder treatment. METHODS: A qualitative design with focus groups of student pharmacists in a U.S. college of pharmacy in the Southeastern United States. RESULTS: Over 2 months in 2020, three focus groups were conducted with 15 students in each group participating, and including second-, third-, and fourth-year student pharmacists. Three overarching themes emerged from the data: (1) student pharmacists desire exposure to therapeutic knowledge and lived experiences related to opioid use disorder and methadone treatment, (2) students perceive stigmatizing views held by practicing pharmacists toward opioid use disorder and methadone treatment, (3) pharmacists should play a role in methadone treatment. CONCLUSION: Student pharmacists desire an active and larger role in the care of patients managing opioid use disorder. Findings indicate these students perceive less stigma toward opioid use disorder than currently practicing pharmacists. Pharmacy curricula should emphasize stories of lived experiences of patients with opioid use disorder, therapeutic knowledge and guidelines related to medications for opioid use disorder, and the regulatory environment surrounding opioid use disorder treatment. SAGE Publications 2021-06-03 /pmc/articles/PMC8182209/ /pubmed/34158941 http://dx.doi.org/10.1177/20503121211022994 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Hohmeier, Kenneth C
Cernasev, Alina
Sensmeier, Megan
Hall, Elizabeth
Webb, Katie
Barenie, Rachel
Cochran, Gerald
U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
title U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
title_full U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
title_fullStr U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
title_full_unstemmed U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
title_short U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
title_sort u.s. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: a qualitative study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182209/
https://www.ncbi.nlm.nih.gov/pubmed/34158941
http://dx.doi.org/10.1177/20503121211022994
work_keys_str_mv AT hohmeierkennethc usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy
AT cernasevalina usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy
AT sensmeiermegan usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy
AT hallelizabeth usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy
AT webbkatie usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy
AT barenierachel usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy
AT cochrangerald usstudentpharmacistperceptionsofthepharmacistsroleinmethadoneforopioidusedisorderaqualitativestudy